NCT06632717
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
463 recruiting studies
Liver Neoplasms trial results
NCT07239245
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, Henan, China
- The First Hospital of China Medical University Shenyang, Liaoning, China
- Shanxi Cancer Hospital Taiyuan, Shanxi, China
NCT07243691
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China Hangzhou, Zhejiang, China
NCT07106827
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +53 more
- Locations
-
- West China Hospital Chengdu, Sichuan, China
NCT05914116
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +52 more
- Locations
-
- Research Site 111 Tucson, Arizona, United States
- Research Site 125 Los Angeles, California, United States
- Research Site 133 Los Angeles, California, United States
- Research Site 103 Los Angeles, California, United States
NCT06915753
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCSF Medical Center at Mount Zion San Francisco, California, United States
- Stanford Cancer Institute Stanford, California, United States
- The University of Kansas Medical Center Westwood, Kansas, United States
NCT07235410
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Recruiting
Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial
NCT05751343
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT06698250
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
- Houston Methodist Neal Cancer Center Houston, Texas, United States
- Mays Cancer Center, UT Health San Antonio San Antonio, Texas, United States
NCT06198296
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States